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In 2011, the Japan Diabetes Society established a 'Committee on Causes of Death in Diabetes Mellitus', which published its final committee report in 2016.[1](#jdi12645-bib-0001){ref-type="ref"} This is the English version of that report with some revisions; produced to enhance the understanding for our non‐Japanese colleagues and other interested parties.

This is the official published version of that report, and has been jointly published in Diabetology International (the official English journal of JDS: doi: [10.1007/s13340‐017‐0313‐3](10.1007/s13340-017-0313-3)) and Journal of Diabetes Investigation (the official journal of the Asian Association for the Study of Diabetes).

Introduction {#jdi12645-sec-0001}
============

The ultimate goal of treatment of diabetic patients is to maintain their quality of life (QOL) as much as possible, like in healthy people, and to prolong their lifespan. To assess the contribution of recent advances in diabetes treatment, surveys of the causes of death and age at the time of death in diabetic patients are important. 'Study on the prevention and suppression of the development of vascular complications in diabetic patients' (Japan Diabetes Complications study: JDC study)[2](#jdi12645-bib-0002){ref-type="ref"} and 'A large‐scale observational study to investigate the current status of diabetic complications and their prevention in Japan' (Japan Diabetes Complication and its Prevention prospective study: JDCP study)[3](#jdi12645-bib-0003){ref-type="ref"}, [4](#jdi12645-bib-0004){ref-type="ref"} have clarified the clinical features of Japanese patients with diabetes; however, these studies had limitations with respect to sample size and did not include analyses of the causes of death in diabetic patients.

Previously, three questionnaire surveys were carried out to investigate the causes of death in Japanese diabetic patients[5](#jdi12645-bib-0005){ref-type="ref"}, [6](#jdi12645-bib-0006){ref-type="ref"}, [7](#jdi12645-bib-0007){ref-type="ref"}. The present questionnaire survey was conducted in a similar manner to that of the three previous surveys by the Committee of Japan Diabetes Society on the Causes of Death in Diabetes Mellitus. In this study, we investigated the causes of death among Japanese diabetic patients between 2001 and 2010, and compared the data with the results of previous surveys.

Methods {#jdi12645-sec-0002}
=======

The survey period comprised 10 years from January 1, 2001, to December 31, 2010. The survey contained the following items: 1) sex, 2) body height, 3) maximum body weight, 4) age at the time of death, 5) year and month of death, 6) estimated age of onset of diabetes, 7) duration of treatment for diabetes, 8) type of diabetes, 9) cause of death, 10) diabetic complications while alive, 11) details of treatment for diabetes, 12) source of diagnosis of the cause of death, and 13) most recent hemoglobin A1c (HbA1c) (JDS) level (converted to National Glycohemoglobin Standardization Program \[NGSP\] units for analyses). Five of the questions (1, 4, 8, 9 and 11) were mandatory. The contents of the questionnaire were slightly different from those of the three previous studies, but most of the contents remained the same to allow comparison with the results of previous surveys.

As in the previous surveys, we sent survey forms to 1,164 institutions that met the criterion of an institution that presented papers at an Annual Meeting of the Japan Diabetes Society during the previous 5 years (2006--2010). Although the subjects in the previous surveys were limited to patients who were being treated in the department of diabetes at the time of death, the subjects in the present study were those who were being treated in any of the departments in the institution at the time of death. We received responses from 241 institutions (20.7% response rate), covering 45,970 diabetic patients (22,182 collected by Web‐based questionnaire and 23,788 collected by paper‐based questionnaire). Exclusion of survey forms with internal inconsistencies or missing important data left an analysis group of 45,708 subjects (29,801 men and 15,907 women). Because some data were missing in some of these forms, however, subject number will not be the same for all parameters. Results are for all subjects unless specified as pertaining to autopsy cases.

We analyzed in particular the relationship between vascular diseases (chronic renal failure including diabetic nephropathy, ischemic heart diseases and cerebrovascular diseases) as the cause of death, and patient characteristics including age, sex, glycemic control status, duration of diabetes, details of treatment for diabetes and main complications.

Results {#jdi12645-sec-0003}
=======

Causes of death in Japanese patients with diabetes {#jdi12645-sec-0004}
--------------------------------------------------

### Comparison between all subjects and autopsy cases {#jdi12645-sec-0005}

The results of this survey of causes of death in Japanese diabetic patients are shown for all the cases and autopsy cases in Tables [1](#jdi12645-tbl-0001){ref-type="table-wrap"} and [2](#jdi12645-tbl-0002){ref-type="table-wrap"}, respectively.

###### 

Causes of death in Japanese diabetic patients ‐ study of a total number of 45,708 cases during 2001--2010

  Sex and number                                        Male   29,801   Female   15,907   Total   45,708
  ----------------------------------------------------- ------ -------- -------- -------- ------- --------
  Causes of death                                                                                 
  Vascular diseases                                     13.8   4,126    17.0     2,698    14.9    6,824
  Chronic renal failure                                 3.1    924      4.3      689      3.5     1,613
  Diabetic nephropathy                                  2.5    746      3.5      557      2.9     1,303
  Non‐diabetic nephropathy                              0.6    178      0.8      132      0.7     310
  Ischemic heart diseases                               4.5    1,342    5.3      841      4.8     2,183
  Myocardial infarction                                 4.2    1,258    4.9      777      4.5     2,035
  Angina pectoris                                       0.3    84       0.4      64       0.3     148
  Cerebrovascular diseases                              6.2    1,860    7.3      1,168    6.6     3,028
  Hemorrhage                                            2.2    650      1.8      294      2.1     944
  Infarction                                            3.1    929      4.1      652      3.5     1,581
  Subarachnoidal hemorrhage                             0.4    127      0.9      146      0.6     273
  Others                                                0.5    154      0.5      76       0.5     230
  Heart diseases (other than ischemic heart diseases)   7.5    2,238    10.8     1,717    8.7     3,955
  Arrythmia                                             0.9    272      0.8      121      0.9     393
  Heart failure                                         5.4    1,622    8.6      1,372    6.6     2,994
  Others                                                1.2    344      1.4      224      1.2     568
  Diabetic coma                                         0.5    154      0.8      127      0.6     281
  Hypoglycemic coma                                     0.2    49       0.2      30       0.2     79
  Malignant neoplasia                                   40.7   12,115   33.9     5,395    38.3    17,510
  Esophagus                                             1.4    407      0.4      62       1.0     469
  Stomach                                               4.0    1,189    2.4      389      3.5     1,578
  Lung                                                  8.9    2,658    3.5      555      7.0     3,213
  Colon                                                 2.7    799      2.6      418      2.7     1,217
  Liver                                                 6.7    2,007    4.7      741      6.0     2,748
  Pancreas                                              5.5    1,628    6.1      972      5.7     2,600
  Uterus                                                0.0    0        1.4      230      0.5     230
  Breast                                                0.0    6        1.8      282      0.6     288
  Leukemia/lymphoma                                     4.0    1,193    3.6      573      3.9     1,766
  Others                                                7.5    2,228    7.4      1,173    7.4     3,401
  Infectious diseases                                   17.6   5,255    15.8     2,516    17.0    7,771
  Tuberculosis                                          0.3    86       0.2      37       0.3     123
  Pneumonia                                             12.7   3,784    9.6      1,528    11.6    5,312
  Others                                                4.6    1,385    6.0      951      5.1     2,336
  Liver cirrhosis                                       3.3    971      3.4      544      3.3     1,515
  Type B                                                0.3    94       0.2      33       0.3     127
  Type C                                                1.3    402      1.8      280      1.5     682
  NAFLD                                                 0.1    23       0.1      23       0.1     46
  Others                                                1.5    452      1.3      208      1.4     660
  Suicide                                               0.3    77       0.3      52       0.3     129
  Others                                                13.3   3,977    14.9     2,375    13.9    6,352
  Unknown                                               2.8    839      2.8      453      2.8     1,292

NAFLD, non‐alcoholic fatty liver disease.

John Wiley & Sons, Ltd

###### 

Causes of death in Japanese diabetic patients ‐ study of 978 autopsy cases during 2001--2010

  Sex and *number*                                      Male   665   Female   313   Total   978
  ----------------------------------------------------- ------ ----- -------- ----- ------- -----
  Causes of death                                                                           
  Vascular diseases                                     13.4   89    18.5     58    15.0    147
  Chronic renal failure                                 2.6    17    3.8      12    3.0     29
  Diabetic nephropathy                                  2.0    13    2.9      9     2.2     22
  Non‐diabetic nephropathy                              0.6    4     1.0      3     0.7     7
  Ischemic heart diseases                               6.8    45    10.2     32    7.9     77
  Myocardial infarction                                 6.8    45    9.6      30    7.7     75
  Angina pectoris                                       0.0    0     0.6      2     0.2     2
  Cerebrovascular diseases                              4.1    27    4.5      14    4.2     41
  Hemorrhage                                            1.4    9     1.3      4     1.3     13
  Infarction                                            1.7    11    1.9      6     1.7     17
  Subarachnoidal hemorrhage                             0.5    3     0.6      2     0.5     5
  Others                                                0.6    4     0.6      2     0.6     6
  Heart diseases (other than ischemic heart diseases)   8.0    53    4.8      15    7.0     68
  Arrythmia                                             0.9    6     1.0      3     0.9     9
  Heart failure                                         6.2    41    1.9      6     4.8     47
  Others                                                0.9    6     1.9      6     1.2     12
  Diabetic coma                                         0.9    6     0.6      2     0.8     8
  Hypoglycemic coma                                     0.3    2     0.0      0     0.2     2
  Malignant neoplasia                                   34.0   226   32.9     103   33.6    329
  Esophagus                                             0.8    5     0.3      1     0.6     6
  Stomach                                               2.1    14    1.0      3     1.7     17
  Lung                                                  6.9    46    3.2      10    5.7     56
  Colon                                                 0.8    5     1.3      4     0.9     9
  Liver                                                 5.7    38    5.1      16    5.5     54
  Pancreas                                              2.6    17    3.5      11    2.9     28
  Uterus                                                0.0    0     1.6      5     0.5     5
  Breast                                                0.0    0     0.0      0     0.0     0
  Leukemia/lymphoma                                     8.9    59    9.3      29    9.0     88
  Others                                                6.3    42    7.7      24    6.7     66
  Infectious diseases                                   20.6   137   21.7     68    21.0    205
  Tuberculosis                                          0.6    4     0.6      2     0.6     6
  Pneumonia                                             13.1   87    10.5     33    12.3    120
  Others                                                6.9    46    10.5     33    8.1     79
  Liver cirrhosis                                       2.7    18    1.9      6     2.5     24
  Type B                                                0.2    1     0.0      0     0.1     1
  Type C                                                0.6    4     1.3      4     0.8     8
  NAFLD                                                 0.0    0     0.0      0     0.0     0
  Others                                                2.0    13    0.6      2     1.5     15
  Suicide                                               0.5    3     0.0      0     0.3     3
  Others                                                18.9   126   17.9     56    18.6    182
  Unknown                                               0.8    5     1.6      5     1.0     10

NAFLD, non‐alcoholic fatty liver disease.

John Wiley & Sons, Ltd

The most frequent cause of all 45,708 death cases was malignant neoplasia, accounting for 17,510 cases (38.3%), followed by infectious diseases in 7,771 (17.0%) and vascular diseases (chronic renal failure, ischemic heart diseases and cerebrovascular diseases) in 6,824 (14.9%). The most common malignancy was lung cancer in 3,213 cases (7.0%), followed by liver cancer in 2,748 (6.0%) and pancreatic cancer in 2,600 (5.7%). Of the deaths from vascular diseases, ischemic heart diseases and cerebrovascular diseases accounted for 2,183 (4.8%) and 3,028 (6.6%), respectively, and those from chronic renal failure accounted for 1,613 (3.5%). Regarding ischemic heart diseases, angina pectoris was the cause of death in only 0.3% of cases, and almost all the deaths from ischemic heart diseases were due to myocardial infarction. A total of 3,955 subjects (8.7%) died from heart diseases other than ischemic heart diseases, and most of them (2,994, 6.6%) were due to heart failure. Of the deaths from cerebrovascular diseases, cerebral infarction, the cause of death in 1,581 cases (3.5%), was 1.7‐times more common than cerebral hemorrhage, the cause of death in 944 cases (2.1%). Of the deaths from infectious diseases, 5,312 (11.6%) cases were from pneumonia, accounting for 68% of all the deaths from infectious diseases. Diabetic coma was the cause of death in 281 cases (0.6%) and hypoglycemic coma in 79 cases (0.2%).

Analysis of differences between the sexes showed that malignant neoplasia was the more common cause of death in men (40.7%) than in women (33.9%). In particular, esophageal cancer, gastric cancer, lung cancer and liver cancer were frequently observed. Deaths from vascular diseases were more common in women than in men, and deaths from chronic renal failure, ischemic heart diseases or cerebrovascular diseases had a similar trend. Deaths from heart diseases other than ischemic heart diseases were more common in women than in men. Deaths from infectious diseases were more common in men than in women, and deaths from diabetic coma were slightly more common in women than in men.

An autopsy was performed in 978 cases, accounting for only 2.1% of all cases. The most common cause of death in all the subjects who underwent autopsy was malignant neoplasia, accounting for 329 cases (33.6%), followed by infectious diseases in 205 (21.0%) and vascular diseases in 147 (15.0%). These results, including sex differences, were similar to those for all the surveyed subjects, with deaths from ischemic heart diseases more common and those from cerebrovascular diseases less common.

### Causes of death according to age groups {#jdi12645-sec-0006}

The causes of death for all subjects according to age group are shown in Table [3](#jdi12645-tbl-0003){ref-type="table-wrap"}. The male to female ratio was 1.9:1 for all subjects, 2.6:1 for those aged 40--69 years and 1.6:1 for those aged ≥70 years.

###### 

Causes of death at specified ages in Japanese diabetic patients ‐ study of a total number of 45,708 cases during 2001--2010

  Age at death (years)                                    0˜9          10˜19        20˜29         30˜39         40˜49         50˜59         60˜69         70˜           All age                                                                                                                                                                                                                                                                                               
  ------------------------------------------------------- ------------ ------------ ------------- ------------- ------------- ------------- ------------- ------------- ------------- -------------- ------------- -------------- -------------- -------------- -------------- ---------------- ---------------- ---------------- ---------------- ---------------- ----------------- ----------------- ----------------- ----------------- ----------------- --------------- ---------------
  Causes of death                                         7 (100.0%)   5 (100.0%)   12 (100.0%)   23 (100.0%)   18 (100.0%)   41 (100.0%)   44 (100.0%)   33 (100.0%)   77 (100.0%)   177 (100.0%)   92 (100.0%)   269 (100.0%)   682 (100.0%)   289 (100.0%)   971 (100.0%)   3,010 (100.0%)   1,104 (100.0%)   4,114 (100.0%)   7,599 (100.0%)   2,899 (100.0%)   10,498 (100.0%)   18,192 (100.0%)   11,424 (100.0%)   29,616 (100.0%)   29,734 (100.0%)   15,864 (100%)   45,598 (100%)
  *Vascular diseases*                                     2 (28.6)     1 (20.0)     3 (25.0)      3 (13.0)      1 (5.6)       4 (9.8)       6 (13.6)      1 (3.0)       7 (9.1)       24 (13.6)      14 (15.2)     38 (14.1)      109 (16.0)     39 (13.5)      148 (15.2)     434 (14.4)       132 (12.0)       566 (13.8)       969 (12.8)       391 (13.5)       1,360 (13.0)      2,571 (14.1)      2,114 (18.5)      4,685 (15.8)      4,118 (13.8)      2,693 (17.0)    6,811 (14.9)
  Chronic renal failure                                   0 (0.0)      0 (0.0)      0 (0.0)       0 (0.0)       1 (5.6)       1 (2.4)       1 (2.3)       0 (0.0)       1 (1.3)       4 (2.3)        5 (5.4)       9 (3.3)        10 (1.5)       9 (3.1)        19 (2.0)       68 (2.3)         39 (3.5)         107 (2.6)        202 (2.7)        97 (3.3)         299 (2.8)         638 (3.5)         537 (4.7)         1,175 (4.0)       923 (3.1)         688 (4.3)       1,611 (3.5)
  Diabetic nephropathy                                    0 (0.0)      0 (0.0)      0 (0.0)       0 (0.0)       0 (0.0)       0 (0.0)       0 (0.0)       0 (0.0)       0 (0.0)       2 (1.1)        5 (5.4)       7 (2.6)        6 (0.9)        6 (2.1)        12 (1.2)       58 (1.9)         33 (3.0)         91 (2.2)         158 (2.1)        79 (2.7)         237 (2.3)         521 (2.9)         433 (3.8)         954 (3.2)         745 (2.5)         556 (3.5)       1,301 (2.9)
  Non‐diabetic nephropathy                                0 (0.0)      0 (0.0)      0 (0.0)       0 (0.0)       1 (5.6)       1 (2.4)       1 (2.3)       0 (0.0)       1 (1.3)       2 (1.1)        0 (0.0)       2 (0.7)        4 (0.6)        3 (1.0)        7 (0.7)        10 (0.3)         6 (0.5)          16 (0.4)         44 (0.6)         18 (0.6)         62 (0.6)          117 (0.6)         104 (0.9)         221 (0.7)         178 (0.6)         132 (0.8)       310 (0.7)
  Ischemic heart diseases                                 0 (0.0)      0 (0.0)      0 (0.0)       1 (4.3)       0 (0.0)       1 (2.4)       1 (2.3)       0 (0.0)       1 (1.3)       5 (2.8)        2 (2.2)       7 (2.6)        39 (5.7)       8 (2.8)        47 (4.8)       158 (5.2)        37 (3.4)         195 (4.7)        301 (4.0)        103 (3.6)        404 (3.8)         835 (4.6)         689 (6.0)         1,524 (5.1)       1,340 (4.5)       839 (5.3)       2,179 (4.8)
  Myocardial infarction                                   0 (0.0)      0 (0.0)      0 (0.0)       1 (4.3)       0 (0.0)       1 (2.4)       1 (2.3)       0 (0.0)       1 (1.3)       5 (2.8)        2 (2.2)       7 (2.6)        38 (5.6)       8 (2.8)        46 (4.7)       152 (5.0)        34 (3.1)         186 (4.5)        285 (3.8)        91 (3.1)         376 (3.6)         774 (4.3)         640 (5.6)         1,414 (4.8)       1,256 (4.2)       775 (4.9)       2,031 (4.5)
  Angina pectoris                                         0 (0.0)      0 (0.0)      0 (0.0)       0 (0.0)       0 (0.0)       0 (0.0)       0 (0.0)       0 (0.0)       0 (0.0)       0 (0.0)        0 (0.0)       0 (0.0)        1 (0.1)        0 (0.0)        1 (0.1)        6 (0.2)          3 (0.3)          9 (0.2)          16 (0.2)         12 (0.4)         28 (0.3)          61 (0.3)          49 (0.4)          110 (0.4)         84 (0.3)          64 (0.4)        148 (0.3)
  Cerebrovascular diseases                                2 (28.6)     1 (20.0)     3 (25.0)      2 (8.7)       0 (0.0)       2 (4.9)       4 (9.1)       1 (3.0)       5 (6.5)       15 (8.5)       7 (7.6)       22 (8.2)       60 (8.8)       22 (7.6)       82 (8.4)       208 (6.9)        56 (5.1)         264 (6.4)        466 (6.1)        191 (6.6)        657 (6.3)         1,098 (6.0)       888 (7.8)         1,986 (6.7)       1,855 (6.2)       1,166 (7.3)     3,021 (6.6)
  Hemorrhage                                              1 (14.3)     0 (0.0)      1 (8.3)       1 (4.3)       0 (0.0)       1 (2.4)       1 (2.3)       0 (0.0)       1 (1.3)       6 (3.4)        4 (4.3)       10 (3.7)       34 (5.0)       11 (3.8)       45 (4.6)       116 (3.9)        24 (2.2)         140 (3.4)        178 (2.3)        68 (2.3)         246 (2.3)         312 (1.7)         187 (1.6)         499 (1.7)         649 (2.2)         294 (1.9)       943 (2.1)
  Infarction                                              1 (14.3)     0 (0.0)      1 (8.3)       0 (0.0)       0 (0.0)       0 (0.0)       1 (2.3)       1 (3.0)       2 (2.6)       4 (2.3)        0 (0.0)       4 (1.5)        12 (1.8)       5 (1.7)        17 (1.8)       59 (2.0)         16 (1.4)         75 (1.8)         213 (2.8)        81 (2.8)         294 (2.8)         636 (3.5)         547 (4.8)         1,183 (4.0)       926 (3.1)         650 (4.1)       1,576 (3.5)
  Subarachnoidal hemorrhage                               0 (0.0)      0 (0.0)      0 (0.0)       1 (4.3)       0 (0.0)       1 (2.4)       1 (2.3)       0 (0.0)       1 (1.3)       2 (1.1)        3 (3.3)       5 (1.9)        10 (1.5)       6 (2.1)        16 (1.6)       20 (0.7)         10 (0.9)         30 (0.7)         38 (0.5)         26 (0.9)         64 (0.6)          55 (0.3)          101 (0.9)         156 (0.5)         127 (0.4)         146 (0.9)       273 (0.6)
  Others                                                  0 (0.0)      1 (20.0)     1 (8.3)       0 (0.0)       0 (0.0)       0 (0.0)       1 (2.3)       0 (0.0)       1 (1.3)       3 (1.7)        0 (0.0)       3 (1.1)        4 (0.6)        0 (0.0)        4 (0.4)        13 (0.4)         6 (0.5)          19 (0.5)         37 (0.5)         16 (0.6)         53 (0.5)          95 (0.5)          53 (0.5)          148 (0.5)         153 (0.5)         76 (0.5)        229 (0.5)
  *Heart diseases (other than ischemic heart diseases)*   0 (0.0)      0 (0.0)      0 (0.0)       3 (13.0)      3 (16.7)      6 (14.6)      2 (4.5)       4 (12.1)      6 (7.8)       10 (5.6)       4 (4.3)       14 (5.2)       51 (7.5)       9 (3.1)        60 (6.2)       155 (5.1)        71 (6.4)         226 (5.5)        456 (6.0)        206 (7.1)        662 (6.3)         1,553 (8.5)       1,418 (12.4)      2,971 (10.0)      2,230 (7.5)       1,715 (10.8)    3,945 (8.7)
  Arrythmia                                               0 (0.0)      0 (0.0)      0 (0.0)       0 (0.0)       0 (0.0)       0 (0.0)       0 (0.0)       1 (3.0)       1 (1.3)       1 (0.6)        1 (1.1)       2 (0.7)        15 (2.2)       1 (0.3)        16 (1.6)       25 (0.8)         10 (0.9)         35 (0.9)         78 (1.0)         22 (0.8)         100 (1.0)         152 (0.8)         86 (0.8)          238 (0.8)         271 (0.9)         121 (0.8)       392 (0.9)
  Heart failure                                           0 (0.0)      0 (0.0)      0 (0.0)       1 (4.3)       3 (16.7)      4 (9.8)       1 (2.3)       2 (6.1)       3 (3.9)       6 (3.4)        3 (3.3)       9 (3.3)        26 (3.8)       4 (1.4)        30 (3.1)       87 (2.9)         46 (4.2)         133 (3.2)        300 (3.9)        145 (5.0)        445 (4.2)         1,194 (6.6)       1,167 (10.2)      2,361 (8.0)       1,615 (5.4)       1,370 (8.6)     2,985 (6.5)
  Others                                                  0 (0.0)      0 (0.0)      0 (0.0)       2 (8.7)       0 (0.0)       2 (4.9)       1 (2.3)       1 (3.0)       2 (2.6)       3 (1.7)        0 (0.0)       3 (1.1)        10 (1.5)       4 (1.4)        14 (1.4)       43 (1.4)         15 (1.4)         58 (1.4)         78 (1.0)         39 (1.3)         117 (1.1)         1                 165 (1.4)         372 (1.3)         344 (1.2)         224 (1.4)       568 (1.2)
  *Diabetic coma*                                         0 (0.0)      0 (0.0)      0 (0.0)       3 (13.0)      3 (16.7)      6 (14.6)      4 (9.1)       4 (12.1)      8 (10.4)      13 (7.3)       2 (2.2)       15 (5.6)       14 (2.1)       7 (2.4)        21 (2.2)       12 (0.4)         14 (1.3)         26 (0.6)         29 (0.4)         20 (0.7)         49 (0.5)          79 (0.4)          77 (0.7)          156 (0.5)         154 (0.5)         127 (0.8)       281 (0.6)
  *Hypoglycemic coma*                                     0 (0.0)      0 (0.0)      0 (0.0)       0 (0.0)       0 (0.0)       0 (0.0)       0 (0.0)       1 (3.0)       1 (1.3)       2 (1.1)        1 (1.1)       3 (1.1)        1 (0.1)        2 (0.7)        3 (0.3)        9 (0.3)          3 (0.3)          12 (0.3)         11 (0.1)         4 (0.1)          15 (0.1)          26 (0.1)          19 (0.2)          45 (0.2)          49 (0.2)          30 (0.2)        79 (0.2)
  *Malignant neoplasia*                                   3 (42.9)     4 (80.0)     7 (58.3)      9 (39.1)      6 (33.3)      15 (36.6)     20 (45.5)     9 (27.3)      29 (37.7)     46 (26.0)      27 (29.3)     73 (27.1)      227 (33.3)     108 (37.4)     335 (34.5)     1,382 (45.9)     522 (47.3)       1,904 (46.3)     3,712 (48.8)     1,298 (44.8)     5,010 (47.7)      6,692 (36.8)      3,401 (29.8)      10,093 (34.1)     12,091 (40.7)     5,375 (33.9)    17,466 (38.3)
  Esophagus                                               0 (0.0)      0 (0.0)      0 (0.0)       0 (0.0)       0 (0.0)       0 (0.0)       0 (0.0)       0 (0.0)       0 (0.0)       0 (0.0)        0 (0.0)       0 (0.0)        3 (0.4)        2 (0.7)        5 (0.5)        44 (1.5)         10 (0.9)         54 (1.3)         163 (2.1)        11 (0.4)         174 (1.7)         197 (1.1)         39 (0.3)          236 (0.8)         407 (1.4)         62 (0.4)        469 (1.0)
  Stomach                                                 1 (14.3)     0 (0.0)      1 (8.3)       0 (0.0)       0 (0.0)       0 (0.0)       0 (0.0)       0 (0.0)       0 (0.0)       2 (1.1)        1 (1.1)       3 (1.1)        10 (1.5)       5 (1.7)        15 (1.5)       115 (3.8)        27 (2.4)         142 (3.5)        366 (4.8)        95 (3.3)         461 (4.4)         695 (3.8)         259 (2.3)         954 (3.2)         1,189 (4.0)       387 (2.4)       1,576 (3.5)
  Lung                                                    0 (0.0)      0 (0.0)      0 (0.0)       0 (0.0)       0 (0.0)       0 (0.0)       1 (2.3)       0 (0.0)       1 (1.3)       4 (2.3)        0 (0.0)       4 (1.5)        22 (3.2)       3 (1.0)        25 (2.6)       258 (8.6)        35 (3.2)         293 (7.1)        745 (9.8)        116 (4.0)        861 (8.2)         1,624 (8.9)       398 (3.5)         2,022 (6.8)       2,654 (8.9)       552 (3.5)       3,206 (7.0)
  Colon                                                   0 (0.0)      0 (0.0)      0 (0.0)       0 (0.0)       0 (0.0)       0 (0.0)       0 (0.0)       0 (0.0)       0 (0.0)       3 (1.7)        3 (3.3)       6 (2.2)        15 (2.2)       4 (1.4)        19 (2.0)       89 (3.0)         30 (2.7)         119 (2.9)        256 (3.4)        96 (3.3)         352 (3.4)         434 (2.4)         282 (2.5)         716 (2.4)         797 (2.7)         415 (2.6)       1,212 (2.7)
  Liver                                                   0 (0.0)      2 (40.0)     2 (16.7)      0 (0.0)       0 (0.0)       0 (0.0)       1 (2.3)       0 (0.0)       1 (1.3)       4 (2.3)        0 (0.0)       4 (1.5)        32 (4.7)       4 (1.4)        36 (3.7)       260 (8.6)        38 (3.4)         298 (7.2)        676 (8.9)        171 (5.9)        847 (8.1)         1,027 (5.6)       519 (4.5)         1,546 (5.2)       2,000 (6.7)       734 (4.6)       2,734 (6.0)
  Pancreas                                                0 (0.0)      0 (0.0)      0 (0.0)       0 (0.0)       0 (0.0)       0 (0.0)       0 (0.0)       0 (0.0)       0 (0.0)       3 (1.7)        0 (0.0)       3 (1.1)        33 (4.8)       9 (3.1)        42 (4.3)       224 (7.4)        89 (8.1)         313 (7.6)        545 (7.2)        243 (8.4)        788 (7.5)         818 (4.5)         628 (5.5)         1,446 (4.9)       1,623 (5.5)       969 (6.1)       2,592 (5.7)
  Uterus                                                  0 (0.0)      0 (0.0)      0 (0.0)       0 (0.0)       0 (0.0)       0 (0.0)       0 (0.0)       0 (0.0)       0 (0.0)       0 (0.0)        2 (2.2)       2 (0.7)        0 (0.0)        14 (4.8)       14 (1.4)       0 (0.0)          45 (4.1)         45 (1.1)         0 (0.0)          67 (2.3)         67 (0.6)          0 (0.0)           102 (0.9)         102 (0.3)         0 (0.0)           230 (1.4)       230 (0.5)
  Breast                                                  0 (0.0)      0 (0.0)      0 (0.0)       0 (0.0)       0 (0.0)       0 (0.0)       0 (0.0)       0 (0.0)       0 (0.0)       0 (0.0)        2 (2.2)       2 (0.7)        0 (0.0)        18 (6.2)       18 (1.9)       1 (0.0)          59 (5.3)         60 (1.5)         4 (0.1)          97 (3.3)         101 (1.0)         1 (0.0)           105 (0.9)         106 (0.4)         6 (0.0)           281 (1.8)       287 (0.6)
  Leukemia/lymphoma                                       2 (28.6)     2 (40.0)     4 (33.3)      7 (30.4)      6 (33.3)      13 (31.7)     15 (34.1)     4 (12.1)      19 (24.7)     23 (13.0)      11 (12.0)     34 (12.6)      71 (10.4)      28 (9.7)       99 (10.2)      156 (5.2)        74 (6.7)         230 (5.6)        326 (4.3)        130 (4.5)        456 (4.3)         592 (3.3)         318 (2.8)         910 (3.1)         1,192 (4.0)       573 (3.6)       1,765 (3.9)
  Others                                                  0 (0.0)      0 (0.0)      0 (0.0)       2 (8.7)       0 (0.0)       2 (4.9)       3 (6.8)       5 (15.2)      8 (10.4)      7 (4.0)        8 (8.7)       15 (5.6)       41 (6.0)       21 (7.3)       62 (6.4)       235 (7.8)        115 (10.4)       350 (8.5)        631 (8.3)        272 (9.4)        903 (8.6)         1,304 (7.2)       751 (6.6)         2,055 (6.9)       2,223 (7.5)       1,172 (7.4)     3,395 (7.4)
  *Infectious diseases*                                   1 (14.3)     0 (0.0)      1 (8.3)       2 (8.7)       1 (5.6)       3 (7.3)       1 (2.3)       3 (9.1)       4 (5.2)       25 (14.1)      13 (14.1)     38 (14.1)      67 (9.8)       28 (9.7)       95 (9.8)       311 (10.3)       119 (10.8)       430 (10.5)       934 (12.3)       330 (11.4)       1,264 (12.0)      3,904 (21.5)      2,016 (17.6)      5,920 (20.0)      5,245 (17.6)      2,510 (15.8)    7,755 (17.0)
  Tuberculosis                                            0 (0.0)      0 (0.0)      0 (0.0)       0 (0.0)       0 (0.0)       0 (0.0)       0 (0.0)       0 (0.0)       0 (0.0)       1 (0.6)        0 (0.0)       1 (0.4)        4 (0.6)        0 (0.0)        4 (0.4)        4 (0.1)          2 (0.2)          6 (0.1)          22 (0.3)         0 (0.0)          22 (0.2)          54 (0.3)          35 (0.3)          89 (0.3)          85 (0.3)          37 (0.2)        122 (0.3)
  Pneumonia                                               1 (14.3)     0 (0.0)      1 (8.3)       2 (8.7)       0 (0.0)       2 (4.9)       1 (2.3)       0 (0.0)       1 (1.3)       7 (4.0)        6 (6.5)       13 (4.8)       20 (2.9)       14 (4.8)       34 (3.5)       174 (5.8)        48 (4.3)         222 (5.4)        599 (7.9)        154 (5.3)        753 (7.2)         2,975 (16.4)      1,305 (11.4)      4,280 (14.5)      3,779 (12.7)      1,527 (9.6)     5,306 (11.6)
  Others                                                  0 (0.0)      0 (0.0)      0 (0.0)       0 (0.0)       (5.6)         1 (2.4)       0 (0.0)       3 (9.1)       3 (3.9)       17 (9.6)       7 (7.6)       24 (8.9)       43 (6.3)       14 (4.8)       57 (5.9)       133 (4.4)        69 (6.3)         202 (4.9)        313 (4.1)        176 (6.1)        489 (4.7)         875 (4.8)         676 (5.9)         1,551 (5.2)       1,381 (4.6)       946 (6.0)       2,327 (5.1)
  *Liver cirrhosis*                                       0 (0.0)      0 (0.0)      0 (0.0)       0 (0.0)       0 (0.0)       0 (0.0)       0 (0.0)       0 (0.0)       0 (0.0)       7 (4.0)        1 (1.1)       8 (3.0)        65 (9.5)       24 (8.3)       89 (9.2)       201 (6.7)        53 (4.8)         254 (6.2)        324 (4.3)        158 (5.5)        482 (4.6)         370 (2.0)         305 (2.7)         675 (2.3)         967 (3.3)         541 (3.4)       1,508 (3.3)
  Type B                                                  0 (0.0)      0 (0.0)      0 (0.0)       0 (0.0)       0 (0.0)       0 (0.0)       0 (0.0)       0 (0.0)       0 (0.0)       0 (0.0)        0 (0.0)       0 (0.0)        8 (1.2)        2 (0.7)        10 (1.0)       28 (0.9)         6 (0.5)          34 (0.8)         30 (0.4)         10 (0.3)         40 (0.4)          28 (0.2)          15 (0.1)          43 (0.1)          94 (0.3)          33 (0.2)        127 (0.3)
  Type C                                                  0 (0.0)      0 (0.0)      0 (0.0)       0 (0.0)       0 (0.0)       0 (0.0)       0 (0.0)       0 (0.0)       0 (0.0)       2 (1.1)        1 (1.1)       3 (1.1)        23 (3.4)       5 (1.7)        28 (2.9)       61 (2.0)         22 (2.0)         83 (2.0)         132 (1.7)        89 (3.1)         221 (2.1)         181 (1.0)         160 (1.4)         341 (1.2)         399 (1.3)         277 (1.7)       676 (1.5)
  NAFLD                                                   0 (0.0)      0 (0.0)      0 (0.0)       (0.0)         0 (0.0)       0 (0.0)       0 (0.0)       0 (0.0)       0 (0.0)       0 (0.0)        0 (0.0)       0 (0.0)        1 (0.1)        0 (0.0)        1 (0.1)        8 (0.3)          2 (0.2)          10 (0.2)         7 (0.1)          5 (0.2)          12 (0.1)          7 (0.0)           16 (0.1)          23 (0.1)          23 (0.1)          23 (0.1)        46 (0.1)
  Others                                                  0 (0.0)      0 (0.0)      0 (0.0)       0 (0.0)       0 (0.0)       0 (0.0)       0 (0.0)       0 (0.0)       0 (0.0)       5 (2.8)        0 (0.0)       5 (1.9)        33 (4.8)       17 (5.9)       50 (5.1)       104 (3.5)        23 (2.1)         127 (3.1)        155 (2.0)        54 (1.9)         209 (2.0)         154 (0.8)         114 (1.0)         268 (0.9)         451 (1.5)         208 (1.3)       659 (1.4)
  *Suicide*                                               0 (0.0)      0 (0.0)      0 (0.0)       0 (0.0)       0 (0.0)       0 (0.0)       0 (0.0)       2 (6.1)       2 (2.6)       2 (1.1)        6 (6.5)       8 (3.0)        5 (0.7)        3 (1.0)        8 (0.8)        13 (0.4)         5 (0.5)          18 (0.4)         24 (0.3)         16 (0.6)         40 (0.4)          33 (0.2)          20 (0.2)          53 (0.2)          77 (0.3)          52 (0.3)        129 (0.3)
  *Others*                                                1 (14.3)     0 (0.0)      1 (8.3)       3 (13.0)      3 (16.7)      6 (14.6)      9 (20.5)      3 (9.1)       12 (15.6)     35 (19.8)      19 (20.7)     54 (20.1)      106 (15.5)     55 (19.0)      161 (16.6)     382 (12.7)       150 (13.6)       532 (12.9)       908 (11.9)       390 (13.5)       1,298 (12.4)      2,522 (13.9)      1,749 (15.3)      4,271 (14.4)      3,966 (13.3)      2,369 (14.9)    6,335 (13.9)
  *Unknown*                                               0 (0.0)      0 (0.0)      0 (0.0)       0 (0.0)       1 (5.6)       1 (2.4)       2 (4.5)       6 (18.2)      8 (10.4)      13 (7.3)       5 (5.4)       18 (6.7)       37 (5.4)       14 (4.8)       51 (5.3)       111 (3.7)        35 (3.2)         146 (3.5)        232 (3.1)        86 (3.0)         318               442 (2.4)         305 (2.7)         747 (2.5)         837 (2.8)         452 (2.8)       1,289 (2.8)

NAFLD, non‐alcoholic fatty liver disease.

John Wiley & Sons, Ltd

The mortality rate as a result of vascular diseases was 13--16% for subjects aged ≥30, with no significant difference among the age groups, and it was higher in men than in women for subjects aged 40--59 years. The mortality rate as a result of chronic renal failure due to diabetic nephropathy was not reported in subjects aged ≤29 years, and it was approximately 2--3% for subjects aged ≥30 years. The mortality rate as a result of myocardial infarction increased to approximately 4--5% for subjects aged ≥40 years. The mortality rate as a result of cerebrovascular diseases was 6--8% for subjects aged ≥30 years, with deaths from cerebral hemorrhage being more common for subjects aged ≤49 years and those from cerebral infarction more prevalent for subjects aged ≥60 years.

The mortality rate as a result of malignant neoplasia was as high as 46.3% for subjects aged 50--59 years and 47.7% for those aged 60--69 years, and those aged ≥51 years accounted for 97.4% of deaths from malignant neoplasia. In addition, the proportion of death from leukemia and lymphoma was high in the subjects aged ≤29 years.

The mortality rate as a result of pneumonia increased with age, reaching 20.0% in the subjects aged ≥70 years, and 80.7% of deaths from pneumonia were found in the subjects aged ≥70 years.

The mortality rate as a result of diabetic coma was as high as 14.6% in the subjects aged 10--19 years and 10.4% in those aged 20--29 years, and it was the second most frequent cause of death following malignant neoplasia in these age groups.

Glycemic control, duration of diabetes, cause of death and age at death {#jdi12645-sec-0007}
-----------------------------------------------------------------------

### Glycemic control, cause of death and age at death {#jdi12645-sec-0008}

Table [4](#jdi12645-tbl-0004){ref-type="table-wrap"} shows the cause of death, level of glycemic control and average age at the time of death in 20,348 subjects in whom HbA1c levels were measured (the levels of glycemic control were divided into two groups: better \<8.4% and poorer ≥8.4% in NGSP levels).

###### 

Causes of death, average age at death and glycemic control in Japanaese diabetic patients ‐ study of a total number of 45,708 cases during 2001--2010

  Glycemic control                                      Better (*n = *16,911)   Poorer (*n = *3,437)   Total (*n = *20,348)                                      
  ----------------------------------------------------- ----------------------- ---------------------- ---------------------- ------ ------ ------ ------ ------ ------
  Causes of death                                                                                                                                                
  Vascular diseases                                     72.3                    77.6                   74.4                   68.8   77.2   72.0   71.7   77.5   74.0
  Chronic renal failure                                 73.7                    77.9                   75.5                   72.1   73.3   72.6   73.5   77.5   75.2
  Diabetic nephropathy                                  74.3                    78.0                   75.8                   71.2   71.0   71.1   74.0   77.3   75.4
  Non‐diabetic nephropathy                              71.6                    77.8                   74.5                   74.2   82.0   77.1   71.9   78.2   74.7
  Ischemic heart diseases                               71.6                    77.7                   74.2                   66.7   79.4   71.2   70.5   78.0   73.5
  Myocardial infarction                                 71.4                    77.8                   74.0                   66.2   79.5   70.9   70.2   78.1   73.3
  Angina pectoris                                       75.1                    76.9                   76.0                   79.6   77.0   78.6   75.7   76.9   76.3
  Cerebrovascular diseases                              72.1                    77.3                   74.0                   70.1   76.6   72.7   71.8   77.1   73.8
  Hemorrhage                                            68.6                    72.0                   69.6                   68.5   75.1   69.9   68.6   72.4   69.6
  Infarction                                            75.1                    80.7                   77.3                   71.0   77.4   74.1   74.4   80.0   76.6
  Subarachnoidal hemorrhage                             68.2                    74.2                   71.5                   71.4   75.0   73.3   68.7   74.3   71.8
  Others                                                72.2                    75.4                   73.2                   69.8   70.0   69.8   71.8   74.8   72.8
  Heart diseases (other than ischemic heart diseases)   74.4                    79.3                   76.4                   72.2   76.1   74.0   74.1   78.7   76.1
  Arrythmia                                             72.0                    73.5                   72.5                   65.5   72.4   67.5   71.2   73.4   71.8
  Heart failure                                         75.6                    80.5                   77.8                   73.5   77.4   75.5   75.3   79.9   77.4
  Others                                                70.0                    73.9                   71.4                   70.7   68.7   69.9   70.1   72.9   71.1
  Diabetic coma                                         68.8                    76.4                   72.1                   63.5   66.7   65.2   65.8   69.9   67.8
  Hypoglycemic coma                                     71.7                    76.9                   73.8                   57.3   66.0   63.1   69.3   72.8   70.9
  Malignant neoplasia                                   70.1                    71.7                   70.6                   69.3   70.9   69.8   69.9   71.6   70.4
  Esophagus                                             69.9                    76.0                   70.7                   68.9   69.4   69.0   69.8   74.9   70.5
  Stomach                                               71.8                    73.8                   72.3                   70.2   73.2   71.0   71.7   73.7   72.2
  Lung                                                  71.5                    74.5                   72.0                   70.8   74.3   71.4   71.3   74.4   71.9
  Colon                                                 70.4                    74.3                   71.7                   69.2   73.2   70.3   70.2   74.2   71.5
  Liver                                                 69.6                    73.5                   70.6                   68.1   71.2   69.0   69.5   73.2   70.5
  Pancreas                                              68.6                    71.7                   69.7                   68.8   73.4   70.3   68.6   72.1   69.9
  Uterus                                                0.0                     67.2                   67.2                   0.0    65.9   65.9   0.0    67.0   67.0
  Breast                                                62.7                    67.2                   67.1                   0.0    62.0   62.0   62.7   66.0   65.9
  Leukemia/lymphoma                                     66.4                    68.0                   66.9                   67.7   69.1   68.1   66.5   68.2   67.0
  Others                                                70.7                    71.4                   70.9                   68.8   70.0   69.1   70.4   71.2   70.7
  Infectious diseases                                   75.0                    77.7                   75.9                   73.3   75.5   74.1   74.7   77.3   75.6
  Tuberculosis                                          72.0                    80.5                   74.9                   64.0   80.7   72.3   71.4   80.5   74.7
  Pneumonia                                             76.4                    79.5                   77.3                   74.7   78.0   75.6   76.1   79.3   77.0
  Others                                                71.4                    74.6                   72.7                   69.9   72.9   71.3   71.1   74.2   72.4
  Liver cirrhosis                                       65.4                    69.8                   67.0                   61.5   71.9   66.1   64.9   70.2   66.9
  Type B                                                64.6                    63.7                   64.4                   61.6   74.5   63.9   63.9   65.5   64.3
  Type C                                                67.3                    71.1                   68.9                   63.9   71.1   67.8   67.0   71.1   68.8
  NAFLD                                                 66.9                    75.6                   71.9                   0.0    79.0   79.0   66.9   76.2   72.6
  Others                                                63.5                    67.4                   64.6                   60.2   71.5   65.1   63.0   68.4   64.7
  Suicide                                               64.2                    63.1                   63.8                   69.3   63.1   65.4   64.7   63.1   64.1
  Others                                                71.5                    76.1                   73.2                   70.6   73.8   71.8   71.4   75.6   73.0
  Unknown                                               71.0                    74.3                   72.1                   66.0   68.3   66.9   69.8   72.6   70.8
  All the causes                                        71.6                    75.1                   72.8                   70.0   73.5   71.2   71.4   74.9   72.6

Values are years. NAFLD, non‐alcoholic fatty liver disease.

John Wiley & Sons, Ltd

The average age at the time of death was 72.6 years in all the subjects, and was 1.6 years shorter in subjects with poorer glycemic control than in those with better glycemic control. Lifespans were longer for those with better control with almost all the causes of death, and this difference was smaller for deaths as a result of malignant neoplasms (0.8 years) and greater for deaths as a result of vascular disease (2.4 years), in particular, renal failure due to diabetic nephropathy (4.7 years). On the other hand, for subjects who died from renal failure other than diabetic nephropathy, lifespans were 2.6 years longer in subjects with poorer glycemic control. In addition, for subjects who died from diabetic coma or hypoglycemic coma, lifespans were shorter in those with poorer glycemic control (6.9 years and 10.7 years, respectively). For subjects who died from arrhythmia as a heart disease other than ischemic heart diseases, lifespans were 5 years shorter in those with poorer glycemic control.

### Glycemic control, duration of diabetes and deaths caused by vascular diseases {#jdi12645-sec-0009}

The data on HbA1c levels and estimated duration of diabetes were available for 1,503 of the 6,824 subjects who died from vascular diseases (Table [5](#jdi12645-tbl-0005){ref-type="table-wrap"}). As approximately 90% of patients had better glycemic control, comparison between those with better and poorer control was difficult, and analysis was carried out only on the relationship between causes of death and duration of diabetes.

###### 

Glycemic control, duration of diabetes and vascular diseases as causes of death in Japanese diabetic patients during 2001--2010

  Glycemic control   Vascular diseases                    Ischemic heart diseases   Cerebrovascular diseases                                                                                                                                                                                                                                                           
  ------------------ ------------------------------ ----- ------------------------- -------------------------- ----- ------------ -------------- ---- ----------- ------------- ----- ------------ -------------- ----- ------------ -------------- ----- ------------ -------------- ---- ----------- ------------- ---- ----------- ------------- ----- ------------ --------------
                     Duration of diabetes (years)   192   139                       331 (100.0%)               316   184          500 (100.0%)   19   15          34 (100.0%)   335   199          534 (100.0%)   138   48           186 (100.0%)   209   142          351 (100.0%)   22   27          49 (100.0%)   36   16          52 (100.0%)   405   233          638 (100.0%)
  Better             ≤4                             28    22                        50 (15.1)                  45    28           73 (14.6)      6    5           11 (32.4)     51    33           84 (15.7)      30    16           46 (24.7)      50    36           86 (24.5)      6    13          19 (38.8)     12   5           17 (32.7)     98    70           168 (26.3)
  5˜9                24                             11    35 (10.6)                 46                         20    66 (13.2)    2              0    2 (5.9)     48            20    68 (12.7)    17             7     24 (12.9)    33             17    50 (14.2)    1              2    3 (6.1)     6             1    7 (13.5)    57            27    84 (13.2)    
  10≤                124                            88    212 (64.0)                149                        93    242 (48.4)   8              10   18 (52.9)   157           103   260 (48.8)   67             20    87 (46.8)    88             60    148 (42.2)   14             8    22 (44.9)   14            9    23 (44.2)   183           97    280 (43.9)   
  Total              176                            121   297 (89.7)                240                        141   381 (76.2)   16             15   31 (91.2)   256           156   412 (77.2)   114            43    157 (84.4)   171            113   284 (80.9)   21             23   44 (89.8)   32            15   47 (90.4)   338           194   532 (83.4)   
  Poorer             ≤5                             1     1                         2 (0.6)                    11    8            19 (3.8)       1    0           1 (2.9)       12    8            20 (3.7)       6     2            8 (4.3)        9     7            16 (4.6)       1    2           3 (6.1)       1    0           1 (1.9)       17    11           28 (4.4)
  5˜10               1                              0     1 (0.3)                   19                         9     28 (5.6)     0              0    0 (0.0)     19            9     28 (5.2)     5              2     7 (3.8)      2              4     6 (1.7)      0              0    0 (0.0)     1             0    1 (1.9)     8             6     14 (2.2)     
  11≤                14                             17    31 (9.4)                  46                         26    72 (14.4)    2              0    2 (5.9)     48            26    74 (13.9)    13             1     14 (7.5)     27             18    45 (12.8)    0              2    2 (4.1)     2             1    3 (5.8)     42            22    64 (10.0)    
  Total              16                             18    34 (10.3)                 76                         43    119 (23.8)   3              0    3 (8.8)     79            43    122 (22.8)   24             5     29 (15.6)    38             29    67 (19.1)    1              4    5 (10.2)    4             1    5 (9.6)     67            39    106 (16.6)   

Values in parentheses are percentage.
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The duration of diabetes was 10 years or more in 73.4% of deaths from diabetic nephropathy, 62.7% of deaths from ischemic heart diseases and 50% of deaths from cerebrovascular diseases.

Relationship between death caused by vascular diseases, treatment for diabetes, and complications and concomitant diseases {#jdi12645-sec-0010}
--------------------------------------------------------------------------------------------------------------------------

### Treatment for diabetes and deaths caused by vascular diseases {#jdi12645-sec-0011}

As shown in Table [6](#jdi12645-tbl-0006){ref-type="table-wrap"}, treatment for diabetes in all the subjects comprised diet alone in 18.8%, oral hypoglycemic agents in 33.9% and insulin in 41.9%, with insulin therapy the most common. In particular, 53.7% of diabetic patients who died from diabetic nephropathy were on insulin therapy, a higher proportion than those who died from ischemic heart diseases (38.9%) or those who died from cerebrovascular diseases (39%). Oral hypoglycemic agent therapy was more common in diabetic patients who died from ischemic heart diseases (34.6%) and cerebrovascular diseases (33.6%) compared with those who died from diabetic nephropathy (28.6%). Diet therapy alone was slightly less common in diabetic patients who died from diabetic nephropathy (13.9%) than in those who died from ischemic heart diseases (16.2%) or cerebrovascular diseases (17.8%). The sum of the percentages exceeds 100 because there were subjects who used both oral hypoglycemic agents and insulin.

###### 

Treatment of diabetes and vascular diseases as cause of death in Japanese Diabetic patients during 2001--2010

  Causes of death            Diabetic nephropathy   Ischemic heart diseases   Cerebrovascular diseases   Others   All                                                                                                                                                                                                                                        
  -------------------------- ---------------------- ------------------------- -------------------------- -------- ----- ----------- ---- ---- ---------- ------- ----- ----------- ----- ----- ---------- ----- ----- ----------- ----- ----- ---------- ----- ----- ----------- ------- ------- ----------- -------- -------- ----------- -------- -------- -----------
  Diet alone                                                                  13.89%                                    16.31%                14.86%                   16.22%                  16.42%                 18.28%                  21.98%                 15.65%                      17.83%                        19.14%                        18.76%
  90                         91                     181                       210                        122      332   14          8    22   224        130     354   104         51    155   172        117   289   20          40    60    28         8     36    324         216     540     4,934       2,568    7,502    5,572       3,005    8,577    
  Oral hypoglycemic agents                                                    28.63%                                    35.18%                27.03%                   34.63%                  30.72%                 37.07%                  27.11%                 29.13%                      33.59%                        34.05%                        33.89%
  218                        155                    373                       440                        276      716   19          21   40   459        297     756   216         74    290   357        229   586   32          42    74    44         23    67    649         368     1,017   8,965       4,381    13,346   10,291      5,201    15,492   
  Insulin                                                                     53.72%                                    38.48%                45.27%                   38.94%                  40.47%                 37.44%                  35.90%                 46.96%                      38.97%                        41.91%                        41.91%
  433                        267                    700                       490                        293      783   36          31   67   526        324     850   260         122   382   357        235   592   46          52    98    70         38    108   733         447     1,180   10,714      5,713    16,427   12,406      6,751    19,157   
  GLP‐1 receptor agonist                                                      0.31%                                     0.15%                 0.00%                    0.14%                   0.11%                  0.38%                   0.00%                  0.43%                       0.26%                         0.19%                         0.20%
  2                          2                      4                         3                          0        3     0           0    0    3          0       3     1           0     1     4          2     6     0           0     0     0          1     1     5           3       8       49          26       75       59          31       90       
  Others                                                                      9.06%                                     11.50%                10.14%                   11.41%                  10.17%                 9.17%                   13.92%                 10.87%                      10.04%                        7.27%                         7.70%
  62                         56                     118                       140                        94       234   12          3    15   152        97      249   65          31    96    75         70    145   21          17    38    16         9     25    177         127     304     1,887       962      2,849    2,278       1,242    3,520    
  Total                      746                    557                       1,303                      1,258    777   2,035       84   64   148        1,342   841   2,183       650   294   944        929   652   1,581       127   146   273        154   76    230         1,860   1,168   3,028       25,853   13,341   39,194      29,801   15,907   45,708
                                                                              (105.60%)                                 (101.62%)             (97.30%)                 (101.33%)               (97.88%)               (102.34%)               (98.90%)               (103.04%)                   (100.69%)                     (102.56%)                     (102.47%)
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### Complications and concomitant diseases, and death from vascular diseases {#jdi12645-sec-0012}

The relationship between complications and concomitant diseases, and deaths from vascular diseases is shown in Table [7](#jdi12645-tbl-0007){ref-type="table-wrap"} (all subjects) and Table [8](#jdi12645-tbl-0008){ref-type="table-wrap"} (autopsy subjects). The incidence of almost all the complications and concomitant diseases was much lower than that in the previous surveys, probably because it was not mandatory to answer the question about complications and concomitant diseases in the present survey. On the other hand, the incidence of complications and concomitant diseases in the autopsy subjects was higher than that of all the subjects, probably because the evaluation of complications and concomitant diseases was based on the autopsy records in which detailed data were available; however, it should be noted that the data may be insufficient for the analysis, because the number of autopsy subjects who died from vascular diseases was as low as 140 subjects, and that only 68% of those who died from diabetic nephropathy were reported to have diabetic nephropathy as a concomitant disease.

###### 

Complications in Japanese diabetic patients with vascular diseases as causes of death ‐ study of a total number of 6,514 cases during 2001--2010

  Vasular diseases                                    Diabetic nephropathy   Ischemic heart diseases   Cerebrovascular diseases                                                                                                                                                                                                                                                                                                                  
  --------------------------------------------------- ---------------------- ------------------------- -------------------------- ------------- ------------- ------------- ----------- ----------- ------------ ------------- ------------- ------------- ------------- ----------- ------------- ------------- ------------ ------------- ----------- ----------- ----------- ------------ ----------- ------------ ------------- ------------ -------------
  Complications                                       746                    557                       1,303                      1,258         777           2,035         84          64          148          1,342         841           2,183         650           294         944           929           652          1,581         127         146         273         154          76          230          1,860         1,168        3,028
  Diabetic nephropathy                                42.1% (314)            41.5% (231)               41.8% (545)                18.0% (227)   18.0% (140)   18.0% (367)   10.7% (9)   12.5% (8)   11.5% (17)   17.6% (236)   17.6% (148)   17.6% (384)   18.9% (123)   8.5% (25)   15.7% (148)   12.6% (117)   10.9% (71)   11.9% (188)   7.9% (10)   5.5% (8)    6.6% (18)   12.3% (19)   10.5% (8)   11.7% (27)   14.5% (269)   9.6% (112)   12.6% (381)
  Kidney diseases other than diabetic nephropathy     1.5 (11)               1.4 (8)                   1.5 (19)                   2.9 (37)      3.0 (23)      2.9 (60)      6.0 (5)     1.6 (1)     4.1 (6)      3.1 (42)      2.9 (24)      3.0 (66)      1.8 (12)      4.1 (12)    2.5 (24)      3.4 (32)      2.8 (18)     3.2 (50)      2.4 (3)     4.1 (6)     3.3 (9)     3.2 (5)      5.3 (4)     3.9 (9)      2.8 (52)      3.4 (40)     3.0 (92)
  Retinopathy                                         17.4 (130)             16.2 (90)                 16.9 (220)                 11.8 (148)    13.0 (101)    12.2 (249)    8.3 (7)     14.1 (9)    10.8 (16)    11.5 (155)    13.1 (110)    12.1 (265)    12.0 (78)     5.4 (16)    10.0 (94)     7.9 (73)      5.7 (37)     7.0 (110)     6.3 (8)     6.2 (9)     6.2 (17)    5.2 (8)      3.9 (3)     4.8 (11)     9.0 (167)     5.6 (65)     7.7 (232)
  Neuropathy                                          13.1 (98)              12.0 (67)                 12.7 (165)                 7.5 (94)      8.2 (64)      7.8 (158)     6.0 (5)     6.3 (4)     6.1 (9)      7.4 (99)      8.1 (68)      7.7 (167)     7.8 (51)      2.4 (7)     6.1 (58)      4.5 (42)      4.6 (30)     4.6 (72)      2.4 (3)     5.5 (8)     4.0 (11)    2.6 (4)      5.3 (4)     3.5 (8)      5.4 (100)     4.2 (49)     4.9 (149)
  Gangrene                                            4.8 (36)               4.8 (27)                  4.8 (63)                   3.4 (43)      2.3 (18)      3.0 (61)      2.4 (2)     0.0 (0)     1.4 (2)      3.4 (45)      2.1 (18)      2.9 (63)      1.5 (10)      1.0 (3)     1.4 (13)      2.6 (24)      1.4 (9)      2.1 (33)      0.8 (1)     0.7 (1)     0.7 (2)     0.6 (1)      1.3 (1)     0.9 (2)      1.9 (36)      1.2 (14)     1.7 (50)
  Cerebrovascular diseases                            16.4 (122)             10.2 (57)                 13.7 (179)                 12.0 (151)    13.8 (107)    12.7 (258)    10.7 (9)    12.5 (8)    11.5 (17)    11.9 (160)    13.7 (115)    12.6 (275)    16.3 (106)    15.3 (45)   16.0 (151)    18.5 (172)    16.3 (106)   17.6 (278)    11.0 (14)   15.1 (22)   13.2 (36)   11.7 (18)    17.1 (13)   13.5 (31)    16.7 (310)    15.9 (186)   16.4 (496)
  Hemorrhage                                          1.2 (9)                0.7 (4)                   1.0 (13)                   0.9 (11)      0.5 (4)       0.7 (15)      2.4 (2)     1.6 (1)     2.0 (3)      1.0 (13)      0.6 (5)       0.8 (18)      6.2 (40)      6.5 (19)    6.3 (59)      1.5 (14)      0.6 (4)      1.1 (18)      3.1 (4)     2.1 (3)     2.6 (7)     0.6 (1)      2.6 (2)     1.3 (3)      3.2 (59)      2.4 (28)     2.9 (87)
  Infarction                                          14.1 (105)             9.5 (53)                  12.1 (158)                 10.7 (134)    12.7 (99)     11.4 (233)    7.1 (6)     10.9 (7)    8.8 (13)     10.4 (140)    12.6 (106)    11.3 (246)    8.6 (56)      7.8 (23)    8.4 (79)      16.0 (149)    15.2 (99)    15.7 (248)    5.5 (7)     6.8 (10)    6.2 (17)    7.1 (11)     9.2 (7)     7.8 (18)     12.0 (223)    11.9 (139)   12.0 (362)
  Subarachnoidalhemorrhage                            0.0 (0)                0.0 (0)                   0.0 (0)                    0.1 (1)       0.1 (1)       0.1 (2)       0.0 (0)     0.0 (0)     0.0 (0)      0.1 (1)       0.1 (1)       0.1 (2)       0.9 (6)       0.3 (1)     0.7 (7)       0.3 (3)       0.0 (0)      0.2 (3)       2.4 (3)     4.1 (6)     3.3 (9)     0.0 (0)      0.0 (0)     0.0 (0)      0.6 (12)      0.6 (7)      0.6 (19)
  Others                                              1.1 (8)                0.0 (0)                   0.6 (8)                    0.4 (5)       0.4 (3)       0.4 (8)       1.2 (1)     0.0 (0)     0.7 (1)      0.4 (6)       0.4 (3)       0.4 (9)       0.6 (4)       0.7 (2)     0.6 (6)       0.6 (6)       0.5 (3)      0.6 (9)       0.0 (0)     2.1 (3)     1.1 (3)     3.9 (6)      5.3 (4)     4.3 (10)     0.9 (16)      1.0 (12)     0.9 (28)
  Ischemic heart diseases                             13.0 (97)              11.3 (63)                 12.3 (160)                 23.6 (297)    22.7 (176)    23.2 (473)    11.9 (10)   28.1 (18)   18.9 (28)    22.9 (307)    23.1 (194)    23.0 (501)    10.0 (65)     4.8 (14)    8.4 (79)      11.1 (103)    10.7 (70)    10.9 (173)    6.3 (8)     8.9 (13)    7.7 (21)    11.7 (18)    11.8 (9)    11.7 (27)    10.4 (194)    9.1 (106)    9.9 (300)
  Myocardial infarction                               7.0 (52)               3.9 (22)                  5.7 (74)                   14.0 (176)    12.4 (96)     13.4 (272)    7.1 (6)     10.9 (7)    8.8 (13)     13.6 (182)    12.2 (103)    13.1 (285)    4.2 (27)      0.3 (1)     3.0 (28)      5.4 (50)      4.1 (27)     4.9 (77)      2.4 (3)     4.1 (6)     3.3 (9)     3.2 (5)      2.6 (2)     3.0 (7)      4.6 (85)      3.1 (36)     4.0 (121)
  Angina pectoris                                     6.0 (45)               7.4 (41)                  6.6 (86)                   9.6 (121)     10.3 (80)     9.9 (201)     4.8 (4)     17.2 (11)   10.1 (15)    9.3 (125)     10.8 (91)     9.9 (216)     5.8 (38)      4.4 (13)    5.4 (51)      5.7 (53)      6.6 (43)     6.1 (96)      3.9 (5)     4.8 (7)     4.4 (12)    8.4 (13)     9.2 (7)     8.7 (20)     5.9 (109)     6.0 (70)     5.9 (179)
  Heart diseases other than ischemic heart diseases   8.2 (61)               12.2 (68)                 9.9 (129)                  8.4 (106)     9.4 (73)      8.8 (179)     11.9 (10)   7.8 (5)     10.1 (15)    8.6 (116)     9.3 (78)      8.9 (194)     4.5 (29)      6.5 (19)    5.1 (48)      8.8 (82)      14.4 (94)    11.1 (176)    3.9 (5)     5.5 (8)     4.8 (13)    9.7 (15)     11.8 (9)    10.4 (24)    7.0 (131)     11.1 (130)   8.6 (261)
  Peripheral artery diseases                          9.0 (67)               6.5 (36)                  7.9 (103)                  6.1 (77)      6.3 (49)      6.2 (126)     8.3 (7)     7.8 (5)     8.1 (12)     6.3 (84)      6.4 (54)      6.3 (138)     2.0 (13)      2.4 (7)     2.1 (20)      4.4 (41)      3.4 (22)     4.0 (63)      1.6 (2)     2.1 (3)     1.8 (5)     5.8 (9)      1.3 (1)     4.3 (10)     3.5 (65)      2.8 (33)     3.2 (98)
  Hypertension                                        26.1 (195)             34.3 (191)                29.6 (386)                 27.2 (342)    32.9 (256)    29.4 (598)    25.0 (21)   28.1 (18)   26.4 (39)    27.0 (363)    32.6 (274)    29.2 (637)    32.5 (211)    25.2 (74)   30.2 (285)    28.1 (261)    27.1 (177)   27.7 (438)    24.4 (31)   25.3 (37)   24.9 (68)   25.3 (39)    23.7 (18)   24.8 (57)    29.1 (542)    26.2 (306)   28.0 (848)
  Dyslipidemia                                        7.0 (52)               10.4 (58)                 8.4 (110)                  13.8 (173)    14.9 (116)    14.2 (289)    9.5 (8)     15.6 (10)   12.2 (18)    13.5 (181)    15.0 (126)    14.1 (307)    7.2 (47)      7.1 (21)    7.2 (68)      10.0 (93)     8.3 (54)     9.3 (147)     7.1 (9)     11.0 (16)   9.2 (25)    7.8 (12)     13.2 (10)   9.6 (22)     8.7 (161)     8.6 (101)    8.7 (262)
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###### 

Complications in Japanese diabetic patients with vascular diseases as causes of death ‐ study of 140 autopsy cases during 2001--2010

  Vasular diseases                                    Diabetic nephropathy   Ischemic heart diseases   Cerebrovascular diseases                                                                                                                                                                                                                                                                                       
  --------------------------------------------------- ---------------------- ------------------------- -------------------------- ------------ ----------- ------------ ---------- ---------- ---------- ------------ ----------- ------------ ----------- ----------- ----------- ----------- ----------- ----------- ---------- ----------- ----------- ----------- ----------- ----------- ----------- ----------- ------------
  Complications                                       13                     9                         22                         45           30          75           0          2          2          45           32          77           9           4           13          11          6           17          3          2           5           4           2           6           27          14          41
  Diabetic nephropathy                                69.2% (9)              66.7% (6)                 68.2% (15)                 35.6% (16)   23.3% (7)   30.7% (23)   0.0% (0)   0.0% (0)   0.0% (0)   35.6% (16)   21.9% (7)   29.9% (23)   22.2% (2)   50.0% (2)   30.8% (4)   45.5% (5)   50.0% (3)   47.1% (8)   0.0% (0)   50.0% (1)   20.0% (1)   50.0% (2)   50.0% (1)   50.0% (3)   33.3% (9)   50.0% (7)   39.0% (16)
  Kidney diseases other than diabetic nephropathy     7.7 (1)                11.1 (1)                  9.1 (2)                    6.7 (3)      6.7 (2)     6.7 (5)      0.0 (0)    0.0 (0)    0.0 (0)    6.7 (3)      6.3 (2)     6.5 (5)      0.0 (0)     0.0 (0)     0.0 (0)     9.1 (1)     0.0 (0)     5.9 (1)     0.0 (0)    0.0 (0)     0.0 (0)     0.0 (0)     0.0 (0)     0.0 (0)     3.7 (1)     0.0 (0)     2.4 (1)
  Retinopathy                                         23.1 (3)               33.3 (3)                  27.3 (6)                   17.8 (8)     26.7 (8)    21.3 (16)    0.0 (0)    0.0 (0)    0.0 (0)    17.8 (8)     25.0 (8)    20.8 (16)    11.1 (1)    0.0 (0)     7.7 (1)     9.1 (1)     33.3 (2)    17.6 (3)    0.0 (0)    50.0 (1)    20.0 (1)    25.0 (1)    0.0 (0)     16.7 (1)    11.1 (3)    21.4 (3)    14.6 (6)
  Neuropathy                                          23.1 (3)               33.3 (3)                  27.3 (6)                   13.3 (6)     26.7 (8)    18.7 (14)    0.0 (0)    0.0 (0)    0.0 (0)    13.3 (6)     25.0 (8)    18.2 (14)    22.2 (2)    25.0 (1)    23.1 (3)    9.1 (1)     33.3 (2)    17.6 (3)    0.0 (0)    0.0 (0)     0.0 (0)     25.0(1)     0.0 (0)     16.7 (1)    14.8 (4)    21.4 (3)    17.1 (7)
  Gangrene                                            7.7 (1)                0.0 (0)                   4.5 (1)                    6.7 (3)      6.7 (2)     6.7 (5)      0.0 (0)    0.0 (0)    0.0 (0)    6.7 (3)      6.3 (2)     6.5 (5)      0.0 (0)     0.0 (0)     0.0 (0)     0.0 (0)     16.7 (1)    5.9 (1)     0.0 (0)    0.0 (0)     0.0 (0)     0.0 (0)     50.0 (1)    16.7 (1)    0.0 (0)     14.3 (2)    4.9 (2)
  Cerebrovascular diseases                            53.8 (7)               22.2 (2)                  40.9 (9)                   13.3 (6)     30.0 (9)    20.0 (15)    0.0 (0)    0.0 (0)    0.0 (0)    13.3 (6)     28.1 (9)    19.5 (15)    0.0 (0)     25.0 (1)    7.7 (1)     27.3 (3)    16.7 (1)    23.5 (4)    33.3 (1)   0.0 (0)     20.0 (1)    25.0 (1)    0.0 (0)     16.7 (1)    18.5 (5)    14.3 (2)    17.1 (7)
  Hemorrhage                                          7.7 (1)                0.0 (0)                   4.5 (1)                    2.2 (1)      0.0 (0)     1.3 (1)      0.0 (0)    0.0 (0)    0.0 (0)    2.2 (1)      0.0 (0)     1.3 (1)      0.0 (0)     25.0 (1)    7.7 (1)     0.0 (0)     0.0 (0)     0.0 (0)     0.0 (0)    0.0 (0)     0.0 (0)     0.0 (0)     0.0 (0)     0.0 (0)     0.0 (0)     7.1 (1)     2.4 (1)
  Infarction                                          46.2 (6)               22.2 (2)                  36.4 (8)                   11.1 (5)     26.7 (8)    17.3 (13)    0.0 (0)    0.0 (0)    0.0 (0)    11.1 (5)     25.0 (8)    16.9 (13)    0.0 (0)     0.0 (0)     0.0 (0)     27.3 (3)    16.7 (1)    23.5 (4)    0.0 (0)    0.0 (0)     0.0 (0)     0.0 (0)     0.0 (0)     0.0 (0)     11.1 (3)    7.1 (1)     9.8 (4)
  Subarachnoidal hemorrhage                           0.0 (0)                0.0 (0)                   0.0 (0)                    0.0 (0)      0.0 (0)     0.0 (0)      0.0 (0)    0.0 (0)    0.0 (0)    0.0 (0)      0.0 (0)     0.0 (0)      0.0 (0)     0.0 (0)     0.0 (0)     0.0 (0)     0.0 (0)     0.0 (0)     33.3 (1)   0.0 (0)     20.0 (1)    0.0 (0)     0.0 (0)     0.0 (0)     3.7 (1)     0.0 (0)     2.4 (1)
  Others                                              0.0 (0)                0.0 (0)                   0.0 (0)                    0.0 (0)      3.3 (1)     1.3 (1)      0.0 (0)    0.0 (0)    0.0 (0)    0.0 (0)      3.1 (1)     1.3 (1)      0.0 (0)     0.0 (0)     0.0 (0)     0.0 (0)     0.0 (0)     0.0 (0)     0.0 (0)    0.0 (0)     0.0 (0)     25.0 (1)    0.0 (0)     16.7 (1)    3.7 (1)     0.0 (0)     2.4 (1)
  Ischemic heart diseases                             46.2 (6)               22.2 (2)                  36.4 (8)                   35.6 (16)    40.0 (12)   37.3 (28)    0.0 (0)    0.0 (0)    0.0 (0)    35.6 (16)    37.5 (12)   36.4 (28)    22.2 (2)    0.0 (0)     15.4 (2)    9.1 (1)     16.7 (1)    11.8 (2)    0.0 (0)    0.0 (0)     0.0 (0)     50.0 (2)    0.0 (0)     33.3 (2)    18.5 (5)    7.1 (1)     14.6 (6)
  Myocardial infarction                               23.1 (3)               11.1 (1)                  18.2 (4)                   22.2 (10)    26.7 (8)    24.0 (18)    0.0 (0)    0.0 (0)    0.0 (0)    22.2 (10)    25.0 (8)    23.4 (18)    11.1 (1)    0.0 (0)     7.7 (1)     9.1 (1)     16.7 (1)    11.8 (2)    0.0 (0)    0.0 (0)     0.0 (0)     25.0 (1)    0.0 (0)     16.7 (1)    11.1 (3)    7.1 (1)     9.8 (4)
  Angina pectoris                                     23.1 (3)               11.1 (1)                  18.2 (4)                   13.3 (6)     13.3 (4)    13.3 (10)    0.0 (0)    0.0 (0)    0.0 (0)    13.3 (6)     12.5 (4)    13.0 (10)    11.1 (1)    0.0 (0)     7.7 (1)     0.0 (0)     0.0 (0)     0.0 (0)     0.0 (0)    0.0 (0)     0.0 (0)     25.0 (1)    0.0 (0)     16.7 (1)    7.4 (2)     0.0 (0)     4.9 (2)
  Heart diseases other than ischemic heart diseases   0.0 (0)                11.1 (1)                  4.5 (1)                    8.9 (4)      20.0 (6)    13.3 (10)    0.0 (0)    0.0 (0)    0.0 (0)    8.9 (4)      18.8 (6)    13.0 (10)    11.1 (1)    25.0 (1)    15.4 (2)    18.2 (2)    16.7 (1)    17.6 (3)    0.0 (0)    0.0 (0)     0.0 (0)     25.0 (1)    0.0 (0)     16.7 (1)    14.8 (4)    14.3 (2)    14.6 (6)
  Peripheral artery diseases                          0.0 (0)                11.1 (1)                  4.5 (1)                    15.6 (7)     20.0 (6)    17.3 (13)    0.0 (0)    0.0 (0)    0.0 (0)    15.6 (7)     18.8 (6)    16.9 (13)    0.0 (0)     0.0 (0)     0.0 (0)     9.1 (1)     16.7 (1)    11.8 (2)    0.0 (0)    0.0 (0)     0.0 (0)     0.0 (0)     0.0 (0)     0.0 (0)     3.7 (1)     7.1 (1)     4.9 (2)
  Hypertension                                        38.5 (5)               66.7 (6)                  50.0 (11)                  48.9 (22)    56.7 (17)   52.0 (39)    0.0 (0)    0.0 (0)    0.0 (0)    48.9 (22)    53.1 (17)   50.6 (39)    33.3 (3)    75.0 (3)    46.2 (6)    45.5 (5)    50.0 (3)    47.1 (8)    33.3 (1)   0.0 (0)     20.0 (1)    25.0 (1)    50.0 (1)    33.3 (2)    37.0 (10)   50.0 (7)    41.5 (17)
  Dyslipidemia                                        15.4 (2)               33.3 (3)                  22.7 (5)                   24.4 (11)    26.7 (8)    25.3 (19)    0.0 (0)    0.0 (0)    0.0 (0)    24.4 (11)    25.0 (8)    24.7 (19)    22.2 (2)    25.0 (1)    23.1 (3)    9.1 (1)     16.7 (1)    11.8 (2)    0.0 (0)    0.0 (0)     0.0 (0)     50.0 (2)    0.0 (0)     33.3 (2)    18.5 (5)    14.3 (2)    17.1 (7)
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Diabetic retinopathy and neuropathy were both common in diabetic patients who eventually died from diabetic nephropathy in all the subjects, as well as in the autopsy subjects, and the incidence of coronary artery diseases was high in diabetic patients who died from ischemic heart diseases. Hypertension was present in approximately half of the autopsy subjects who died from vascular diseases, but the presence of dyslipidemia was as low as approximately 20% in those who died from ischemic heart diseases or cerebrovascular diseases. Renal dysfunction was present in 30--40% of subjects who died from ischemic heart diseases or cerebrovascular diseases. Diabetic gangrene was more common in diabetic patients who died from diabetic nephropathy than in those who died from ischemic heart diseases or cerebrovascular diseases.

Discussion {#jdi12645-sec-0013}
==========

Although the questions used in the questionnaire were almost the same as in the three previous surveys, several changes were made in the present survey, including availability of the Web option, making five of the 13 questions mandatory to answer and expanding subjects to patients who were followed up by any of the departments in the institution. As a result, the number of subjects exceeded 45,000, which was approximately 2.5‐times larger than that of the last survey despite that the number of participating institutions decreased from 282 to 241 in the present survey. Although the number of subjects significantly increased, the response rates for non‐mandatory questions were low, which requires improvement in future surveys.

The number of deaths in men was approximately 2‐fold greater than that in women in the present study. According to the National Health and Nutrition Survey in 2010, the number of male diabetic patients was 1.8‐fold greater than that of females[8](#jdi12645-bib-0008){ref-type="ref"}. According to the Outline of the Report of Vital Statistics in 2010 (Tables [6](#jdi12645-tbl-0006){ref-type="table-wrap"}, [7](#jdi12645-tbl-0007){ref-type="table-wrap"}, [8](#jdi12645-tbl-0008){ref-type="table-wrap"}, [9](#jdi12645-tbl-0009){ref-type="table-wrap"}, [10](#jdi12645-tbl-0010){ref-type="table-wrap"} The number of death and mortality \[per 100,000 people\] according to gender and age groups \[by 5 years\] and gender differences), the number of deaths in men was 1.2‐fold greater than that in women in a Japanese general population[9](#jdi12645-bib-0009){ref-type="ref"}. Thus, our data on differences between sexes was in accordance with the above data.

Comparison of the results of the surveys on causes of death in Japanese diabetic patients periodically conducted in the same manner, as well as the results of other Japanese surveys on causes of death, will be of great interest in terms of understanding changes in the clinical features of diabetic patients in Japan, and should also be useful for formulating future strategies. Table [9](#jdi12645-tbl-0009){ref-type="table-wrap"} shows a comparison of the causes of death found in the four surveys, including the present survey, with the causes of death in the Japanese general population over the same period in the Annual Statistical Report of the National Health Condition published by the Health and Welfare Statistics Association in 2010[10](#jdi12645-bib-0010){ref-type="ref"}, [11](#jdi12645-bib-0011){ref-type="ref"}, [12](#jdi12645-bib-0012){ref-type="ref"}, and the Outline of the Report of Vital Statistics in 2010[9](#jdi12645-bib-0009){ref-type="ref"}. In the present study, the most frequent cause of death was malignant neoplasia, followed by infectious diseases as the second most frequent and then vascular diseases. In the first and second surveys, the most frequent cause of death was vascular diseases, and malignant neoplasia was second, followed by infectious diseases, and the top two causes exchanged positions in the third survey. It is noteworthy that the percentage of deaths from vascular diseases further declined and became the third cause. It is also of note that diabetic coma was the cause of death in 281 cases and hypoglycemic coma in 79 cases. Although their proportions are relatively low, clinicians should be aware of this possibility.

###### 

Causes of death in Japanese general population and diabetic patients ‐ comparisons between 1971--1980, 1981--1990, 1991--2000 and 2001--2010

  Causes of death            1971˜1980   1981˜1990   1991˜2000   2001˜2010                        
  -------------------------- ----------- ----------- ----------- ----------- ------ ------ ------ ------
  Vascular diseases          31.7        41.5        24.6        39.3        22.7   26.8   18.8   14.9
  Chronic renal failure      1.0         12.8        2.0         11.2        1.8    6.8    2.0    3.5
  Ischemic heart diseases    6.6         12.3        6.4         14.6        7.3    10.2   6.5    4.8
  Cerebrovascular diseases   24.1        16.4        16.2        13.5        13.6   9.8    10.3   6.6
  Malignant neoplasia        21.6        25.3        25.9        29.2        31.0   34.1   29.5   38.3
  Lung                                                                       5.6    5.3    5.8    7.0
  Liver                                                                      3.5    8.6    2.7    6.0
  Pancreas                                                                   2.0    4.8    2.3    5.7
  Infectious diseases        6.2         9.2         8.4         10.2        9.2    14.3   12.1   17.0
  Others                     40.5        24.1        41.3        21.3        37.1   24.8   39.6   29.8

John Wiley & Sons, Ltd

The proportion of deaths from malignant neoplasia in diabetic patients has increased from 25.3% to 29.2% to 34.1% in the previous three surveys. and to 38.3% in the present survey. On the other hand, the proportion of deaths from malignant neoplasia in the Japanese general population increased from 21.6% to 25.9% to 31.0% every 10 years from 1970 to 2000, but slightly decreased to 29.5% in 2010. This may support the recent findings on the association between diabetes mellitus and cancer. Comparison of the proportions of deaths from malignant neoplasia in the present study with those in the previous surveys showed an increase in deaths from lung cancer and pancreatic cancer and a decrease in deaths from liver cancer, similar to the trend observed in the study of the Japanese general population; however, the proportion of deaths from liver cancer was 2.2‐fold higher and that of deaths from pancreatic cancer was 2.5‐fold higher in diabetic patients than in the Japanese general population. The proportion of deaths from malignant neoplasia has been reported to be slightly higher than that in the pooled analyses by the Committee on Diabetes Mellitus and Cancer[13](#jdi12645-bib-0013){ref-type="ref"}, although the results were not directly comparable to ours.

The proportion of death from vascular diseases has declined in the Japanese general population over the past four decades, and a similar trend was observed in diabetic patients. It was of note that the proportion in diabetic patients decreased from 26.8 to 14.9% (approximately half). For diabetic patients who died from vascular diseases, the proportion of deaths from ischemic heart diseases had decreased from 14.6 to 10.2% (approximately two‐thirds) in the last survey and then greatly decreased to 4.8% in the present study. This is in contrast to the slight decrease in deaths from ischemic heart diseases from 7.3 to 6.5% in the Japanese general population over the same timeframe. In addition, it was interesting that the proportion of deaths from ischemic heart diseases in diabetic patients was lower than that in the Japanese general population, despite that the former had been consistently higher than the latter in the previous surveys. In Japan, the increasing ratio of death from ischemic heart diseases to that from all vascular diseases in diabetic patients was reported in 1967 by Goto *et al*.,[14](#jdi12645-bib-0014){ref-type="ref"} in 1968--1970 by Hirata *et al*.[15](#jdi12645-bib-0015){ref-type="ref"} and in 1960--1984 by Sasaki *et al*.[16](#jdi12645-bib-0016){ref-type="ref"} The recent decrease in the proportion of deaths from ischemic heart diseases in the previous and present surveys may be attributable to the stricter control of blood lipids through the use of statins, and blood pressure through the use of antihypertensive agents, increased awareness of the importance of intensive diabetes management including glycemic control resulting from a wide range of clinical studies, and advances in screening and intervention methods such as coronary artery computed tomography for ischemic heart diseases. On the other hand, the proportion of deaths from cerebrovascular diseases decreased from 16.4% to 13.5% to 9.8% in the previous surveys and to 6.6% in the present survey. This may be a reflection of improvement in the control of blood pressure and blood lipids in general, because a similar trend was observed in the Japanese general population. The proportion of deaths from renal failure in diabetic patients had tended to decrease in the previous surveys and decreased from 6.8 to 3.5% in the present study. On the other hand, the proportion of deaths from renal failure in the Japanese general population showed only a slight increase from 1.8 to 2.0%, which was not a significant change. Although renal failure in the Japanese general population and that in diabetic patients may not be directly comparable, the proportion of deaths from renal failure in diabetic patients compared with that in the Japanese general population is still high, although the ratio has been significantly decreased from 12.8‐fold to 5.6‐fold to 3.8‐fold in the previous surveys and to 1.8‐fold in the present survey. The reason for the decreasing tendency may be the improved treatment for a variety of conditions associated with diabetes mellitus that allowed more diabetic patients to receive dialysis therapy and prevented death from renal failure, leading to an increase in deaths due to malignant neoplasia or pneumonia.

The proportion of deaths from infectious diseases, the third ranking cause of death, has risen slightly in both the Japanese general population and diabetic patients, with a consistently approximately 1.5‐fold higher proportion than in the Japanese general population. This reinforces the importance of considering the susceptibility of diabetic patients to infectious diseases in the course of clinical practice.

Table [10](#jdi12645-tbl-0010){ref-type="table-wrap"} shows a comparison of the mean ages at death of Japanese diabetic patients in the four surveys, including the present study, and life expectancy at birth of the Japanese general population over the same time periods[17](#jdi12645-bib-0017){ref-type="ref"}. Although the life expectancy at birth is not directly comparable to the mean age at death, we used the data for comparison, because there are no data on the mean age at death in the Japanese general population. In the present study, the mean age at death in diabetic patients was 71.4 years in men and 75.1 years in women. In contrast, the mean life expectancy at birth in the Japanese general population in 2010 was 79.6 years in men and 86.3 years in women. As in the previous three surveys, the mean age at death in diabetic patients was lower than the life expectancy at birth in the Japanese general population. However, the difference between age at death in diabetic patients and life expectancy at birth in the Japanese general population became significantly smaller in the present study, being reduced from 9.5--10 years to 8.2 years in men and from 13--14 years to 11.2 years in women. Given that 30 years have passed since the first survey was conducted, we considered that significant advances in treatment and control of diabetes during that time led to the improvement in the prognosis of diabetic patients. We hope that future studies will demonstrate that the life expectancy of diabetic patients is comparable to that of the Japanese general population.

###### 

Mean ages at death of Japanese diabetic patients and life expectancy at birth of Japanese general population ‐ commparisons between 1971--1980, 1981--1990, 1991--2000 and 2001--2010

                                                       1)1971˜1980                                    2)1981˜1990                                    3)1991˜2000                                    4)2001˜2010                                    Differences between 2) and 1)                  Differences between 3) and 2)                  Differences between 4) and 3)                                                                                                    
  ---------------------------------------------------- ---------------------------------------------- ---------------------------------------------- ---------------------------------------------- ---------------------------------------------- ---------------------------------------------- ---------------------------------------------- ---------------------------------------------- ---------------------------------------------- ------ ------ ------ ------ ------ ------
  A. General population (life expectancy in years)     73.4[16](#jdi12645-bib-0016){ref-type="ref"}   78.8[16](#jdi12645-bib-0016){ref-type="ref"}   75.9[16](#jdi12645-bib-0016){ref-type="ref"}   81.9[16](#jdi12645-bib-0016){ref-type="ref"}   77.6[16](#jdi12645-bib-0016){ref-type="ref"}   84.6[16](#jdi12645-bib-0016){ref-type="ref"}   79.6[16](#jdi12645-bib-0016){ref-type="ref"}   86.3[16](#jdi12645-bib-0016){ref-type="ref"}   +2.5   +3.1   +1.7   +2.7   +2.0   +1.7
  B. Diabetic patients (mean ages at death in years)   63.1[4](#jdi12645-bib-0004){ref-type="ref"}    64.9[4](#jdi12645-bib-0004){ref-type="ref"}    66.5[5](#jdi12645-bib-0005){ref-type="ref"}    68.4[5](#jdi12645-bib-0005){ref-type="ref"}    68.0[6](#jdi12645-bib-0006){ref-type="ref"}    71.6[6](#jdi12645-bib-0006){ref-type="ref"}    71.4[17](#jdi12645-bib-0017){ref-type="ref"}   75.1[17](#jdi12645-bib-0017){ref-type="ref"}   +3.4   +3.5   +1.5   +3.2   +3.4   +3.5
  Differences between A and B (B ‐ A)                  −10.3                                          −13.9                                          −9.4                                           −13.5                                          −9.6                                           −13.0                                          −8.2                                           −11.2                                                                             
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There are limitations in interpreting results obtained through questionnaire surveys, such as difficulties in standardizing diagnostic criteria and assessment criteria for the cause of death. However, we can state that the results collated from 45,708 subjects received from 241 institutions throughout the country clarify greatly the clinical features of Japanese diabetic patients in the decade 2001--2010. In the present study, we tabulated the results of the present questionnaire survey, setting them out in the same manner as the previous surveys to facilitate comparison. We sincerely hope that the results presented here will be of use in the treatment of diabetes. We believe that this kind of survey is very important and should be continued in future, because it can clarify the current clinical features of Japanese diabetic patients by comparing the results with previous data.
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